Grant, D. B., Hambley, J., Becker, D., and Pimstone, B. L. (1973) . Archives of Disease in Childhood, 48, 596 . Reduced sulphation factor in undernourished children. Serum sulphation factor (SF) activity was estimated in serial samples from 5 children with protein-calorie malnutrition. Serum growth hormone (HGH), albumin, and transferrin were also measured. SF activity was reduced at the time of admission, but had risen in all patients by the ninth day of treatment. While serum HGH fell during treatment, there was no obvious relation between the changes in SF and HGH in each patient. Serum albumin rose during treatment and showed a correlation with the changes in serum SF. The pattern of recovery in serum transferrin was also similar to that shown by SF.
In 1957, Salmon and Daughaday reported that serum from normal rats stimulated the in vitro incorporation of 35S into costal cartilage from hypophysectomized rats. This serum sulphation factor (SF) activity was reduced in hypophysectomized rats but could be restored by growth hormone injections. Daughaday, Salmon, and Alexander (1959) subsequently showed that human serum also had growth hormone-dependent SF activity, a finding which was soon confirmed by others, and it has been suggested that the growth-promoting effects of HGH may be mediated by SF .
In the rat SF levels are reduced during starvation (Daughaday and Kipnis, 1966) Methods. On the day after admission, blood was taken by venepuncture after an overnight fast, immediately before starting protein supplementation. Further fasting specimens were taken 5, 9, and 22 to 30 days after starting treatment. The last samples were obtained before discharge, at a stage of clinical and biochemical recovery. Serum specimens were stored frozen until used.
Serum SF activity was estimated using a modification of the method described by Hall (1970) . Pelvic rudiments from 11-day chicks were added in random order to glass vials containing 0 95 ml dilute serum. Three pelvic cartilages were added to each vial and observations were made in duplicate, giving 6 cartilages for each serum concentration. 50 mmoll1. HEPES (pH 7*4) was used as diluent. The incubation medium contained penicillin (100 ,4m/ml) and streptomycin (100 /Lg/ml) in addition to salts, amino acids, and glucose at the concentrations used by Hall (1970 containing papain (1 mg), cysteine (2 mg), and EDTA (2 mg), followed by the addition of 0 1 ml N NaOH and further incubation at 60°C for 1 hour. Samples were counted in 15 ml 3:1 v/v toluene: triton with PPO (0-6 g/100 ml) and dimethyl-POPOP (0.02 g/100 ml). The channels ratio method was used to check for quenching, and results were expressed as 35S counts/min per mg cartilage.
In each experiment cartilages were incubated with 5% and 20% serum and all four samples from any one patient were compared with a pooled reference serum from two healthy men. Results were analysed using methods described by Finney (1964) (Morgan and Lazarow, 1963) using HGH obtained from the National Institutes of Health (H S1394) for iodination and as a standard.
Serum albumin was estimated by the biuret method (Wolfson et al., 1948) and transferrin by the method of Mancini, Carbonara, and Heremans (1965) .
Pooled within-patient correlation coefficients were calculated between mean "S uptake in 5% and 20% serum and HGH, albumin, and transferrin levels.
Two-way analysis of variance of SF activity with respect to time, patient-time interaction, and between-patient variation was also done. As the assay error appeared to be proportional to the serum SF activity, log. values for 35S incorporation were used for analysis of variance.
Results
Sulphation factor. Results for 35S incorporation are given in Table I . The values obtained with four specimens from each patient are compared with the results for the control serum in each experiment.
In all 5 patients serum SF activity increased during treatment. In 3 patients a rise was detected 5 days after admission to hospital, and by the ninth day all the patients showed increased serum SF activity. SF results for specimens of serum taken before discharge from hospital were also higher than those obtained for the pretreatment samples. 67-6 (4-9) 94 1 (4 1) 6-7 1*8 2-3 27 76-4 (8-6) 118-8 (10 1) 1.9 3 9 5-6 Control serum 96 *5 (5 *8) 163*6 (6*4) ---2 1 5-8 (3 2) 46-7 (3 2) 6-9 1.9 1-3 5 7-0 (1-3) 51-3 (2-6) 4-6 2-2 1-3 9 28-8 (3-3) 75-4 (5-4) 1-5 2-3 1-7 26 44-7 (10-2) 127-2 (9*3) 2-8 3 9 2-9
Control serum 79*7 (7*3) 143*3 (6*1) (1 0) 30-0 (2-0) 9-6 2-4 2-3 5 11-3 (0 7) 44-1 (1-9) 7-3 2-9 2-1 9 22-8 (1 0) 57-3 (4*3) 13-1 3 0 5 0 30 24-1 (4 9) 58-5 (3 2) (Table I ). The 2 patients who had the lowest serum albumin levels on admission to hospital (Cases 1 and 2) showed the slowest rise in both albumin and SF during treatment. Significant pooled correlation coefficients were obtained between serum albumin concentration and 35S uptake in 5% and 20% serum (r = 0*75 and 0'80, P <001).
Serum transferrin. With the exception of Case 4, there was a marked rise in serum transferrin during treatment (Table I ). In each patient the pattern of recovery in serum transferrin was similar to that shown by serum SF, and significant correlation coefficients were obtained between 35S incorporation in both 5% and 20% serum and serum transferrin concentration (r 0 * 79 and 0 * 78, P <0.01). Discussion The above results indicate that serum SF activity is reduced in patients with PCM but begins to rise soon after treatment is begun.
Though the specimens obtained after 3 to 4 weeks' treatment still appeared to have lower SF activity than serum from healthy adults, relatively low SF levels have been reported in healthy young children (Almqvist and Rune, 1961; Kogut, Kaplan, and Shimizu, 1963) , and the values in our cases may have been normal at the time of discharge from hospital.
We are uncertain as to the significance of discrepancies in the slopes of the dose response for pre-and post-treatment samples in 2 patients. Serum from fasted rats has been reported to contain LE III SF results for adult control serum studied in the presence of early serum samples from Cases 1 and 2 77 0 (10-8) 82-7 (7 8) an inhibitor of 35S incorporation (Salmon, 1972 ), but we were unable to show similar inhibition with our specimens. Alternatively, as the log-dose response in our assay appears sigmoid in shape, the findings in these 2 patients may have been due to our failure to use a high enough concentration of pretreatment serum. Low serum SF levels, which can be restored by HGH therapy, have been a common finding in patients with HGH deficiency (Daughaday et al., 1959; Almqvist, 1960; Hall and Olin, 1972) , and it is widely accepted that HGH secretion plays an important role in controlling serum SF in man. However, the low SF activity in our patients was not due to HGH deficiency, as circulating HGH levels were raised in 4 patients before treatment. It therefore appears that serum SF is not solely dependent on HGH secretion. This association between high serum HGH and low serum SF is similar to the findings described by Laron et al. (1971) in children with apparent 'end-organ unresponsiveness' to HGH. Tanner (1972) has suggested that serum SF may inhibit HGH secretion and has postulated that Laron's patients have high serum HGH levels as a result of failure of the feedback mechanism. Though the slow recovery of SF and albumin in Case 1 paralleled the return of HGH levels to normal, a close correlation between SF and HGH was not found in the other patients, possibly since only single basal HGH estimations were obtained.
The wide range of metabolic abnormalities found in patients with PCM have been recently reviewed by Whitehead and Alleyne (1972) and Pimstone, Becker, and Hansen (1972) . In addition to marked changes in body water, potassium, and magnesium, the plasma amino acid pattern is abnormal and plasma albumin, transferrin, and ,B-lipoprotein are reduced. Serum HGH values are raised and hypoglycaemia is common, despite raised plasma cortisol levels and a reduction in serum insulin. The present investigation does not permit detailed analysis of the relation between these abnormalities and serum SF activity. The results do, however, indicate that serum albumin, transferrin, and SF activity all show similar pattems of recovery in PCM. There is evidence that SF is a peptide which is synthesized by the liver (McConaghey and Sledge, 1970; Van den Brande et al., 1971) and the above findings may reflect an abnormality of protein synthesis by the liver in severe malnutrition. Altematively, low SF levels may be more directly related to one or more of the metabolic and endocrine abnormalities found in PCM, and it is therefore possible that more careful studies on the relation between serum SF and other biochemical changes found in PCM might increase our understanding of the metabolism of SF in man. In particular, the relation between serum SF and plasma amino acid concentration may be of interest.
It is still uncertain whether any of the biochemical changes found in PCM have an adaptive function, or whether they merely represent a general breakdown in homoeostatic mechanisms. has argued that the effect of HGH on growth may be mediated through SF and has pointed out the advantage of a system which permits rapid changes in serum HGH to exert a sustained effect through an intermediary with a much longer half life. If the view that SF mediates the growthpromoting effect of HGH is correct, the low SF levels found in our patients could be advantageous, directing available resources away from long-term requirements, such as growth, and toward more urgent needs. 
